Resistant Hypertension: Detection, Evaluation, and Management
Published: September 13, 2018
- Resistant hypertension (RH) is defined as a blood pressure (BP) of a hypertensive patient that remains elevated above goal in spite of the concurrent use of three antihypertensive agents of different classes.
- Diagnosing RH requires adherence to antihypertensive agents and the exclusion of the “white coat effect” (office BP above goal but out-of-office BP at or below target).
- This is an update to the 2008 American Heart Association (AHA) scientific statement on the detection (diagnosis), evaluation and management of resistant hypertension.
2018 Resistant Hypertension Guideline
Anna F. Dominiczak, MD, Editor-in-Chief of Hypertension, interviews Robert M. Carey, MD, the lead author of the 2018 AHA/ACC Resistant Hypertension guideline.
Supporting Materials
- Commentary: Tackling Resistant Hypertension - Opportunities and Challenges by Rhian M Touyz, MD, PhD
- Top Things to Know: Resistant Hypertension: Detection, Evaluation, & Management
- News Release: Diagnosing and treating resistant hypertension
Recommended Reading
- 2017 Hypertension Clinical Guidelines
- Contributory Risks and Management of Comorbidities of Hypertension, Obesity, Diabetes Mellitus, Hyperlipidemia, Metabolic Syndrome in Chronic Heart Failure
- Impact of Hypertension on Cognitive Function
- Salt Sensitivity of Blood Pressure
- Treatment of Hypertension in Persons With Coronary Artery Disease